UCB Collects the following personal data about you:
1. The SI Reporter's:
a) identification data: including full name, initials, ID code, title, address, e-mail address and telephone number;
b) qualification(*): profession (to determine if you are a HCP, caregiver or a member of the general public);
c) country of residence(*) or if that is not available the is not available, the country where the notification was received or where the review took place;
d) relationship with the Patient to whom the pharmacovigilance report pertains;
e) other information about the SI Reporter that may be required under applicable national law;
2. The Patient's:
a) identification data(*): Patient ID code, initials, medical record number (from general practitioner, specialist, hospital),;
b) information about the Patient’s treating HCP;
c) personal characteristics(*): date of birth or age, gender, weight, height;
d) safety information reported regarding any one of UCB’s products: including but not limited to pregnancy, medication errors, overdose, misuse, lack of efficacy, occupational exposure, abuse, withdrawal reactions, off-label use, drug-food interactions, suspected use of counterfeit / falsified medicine or tampering, unexpected benefits, drug-drug interactions, worsening of an existing disease etc.
e) health data related to an adverse event - to the extent strictly needed to assess the adverse event in accordance with applicable laws: Information regarding the adverse event (seriousness, date, unique identification number, suspected adverse reaction(s)); treatments administered (including start and end dates); information on how the prescribed medicines were used as well as the therapy management; examination results, nature of the adverse effect(s); personal or family history, diseases or associated events, risk factors, lab reports (if applicable); gestation period when reaction/event was observed in the foetus, weight, height or gender, last menstrual date and/or gestation period at time of exposure (to the extent applicable); relevant medical history and concurrent conditions; concomitant medicinal products, which are suspected to be unrelated to the adverse reaction and past-medical drug therapy; Additionally, but only to the extent that this is strictly necessary for the assessment of the adverse event, UCB may also collect and process occupational data (current and past occupations) and information on lifestyle, life habits and behaviours( including for instance: dependence, physical exercise, diet and eating behaviour, etc.);
f) Other safety information which UCB is required to collect in accordance with applicable law;
Failure to provide the personal data with an(*) prevents UCB from reporting the adverse event in accordance with applicable laws.
UCB obtains this personal data from:
- The Patient;
- The SI Reporter;
- Our distributors;
- Partners
- Third party suppliers
UCB retains (**) your personal data for:
- 10 years following the end of the marketing authorisation in any country where the relevant UCB medication was placed on the market
- In the context of quality assurance: relevant information will be retained for 10 years.
UCB shares your personal data with:
- Competent EU or EU Member State regulatory and government agencies/authorities
- UCB affiliates, partners and third-party processors (as detailed in section 5.A)
UCB relies on the following GDPR legal basis:
a) Processing necessary for compliance with our legal obligations (including but not limited to pharmacovigilance/ adverse event reporting legislation);
b) Processing necessary for the performance of a task carried out in the public interest, as pharmacovigilance is a key public health function (i.e. monitoring the safety of medicines, reducing the risks and increasing the benefits of medicines);
c) For health data or other special categories of personal data, the aforementioned legal basis under a) or b) will be coupled with processing necessary for reasons of public interest in the area of public health, such as protecting against serious cross-border threats to health or ensuring high standards of quality and safety of health care and of medicinal products or medical devices, on the basis of Union or Member State law.